Combination therapy targets genetic mutation found in many cancers
Sunday, June 4, 2017 - 16:21
in Health & Medicine
A study has shown promise for effective treatment of therapy-resistant cancers caused by a mutation of the RAS gene found in many cancers. The pre-clinical study combined therapies targeting the inhibitors polyADP ribose polymerase (PARP) and mitogen-activated protein kinase (MEK).